Opus Genetics, Inc. — Director's Dealing 2026

Feb 17, 2026

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Opus Genetics, Inc. (IRD)
CIK: 0001228627
Period of Report: 2026-02-12

Reporting Person: Jayagopal Ashwath (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2026-02-12	Common Stock	F	5313	$3.39	Disposed	520494	Direct

Footnotes

F1: The Issuer withheld the shares reported on this line to satisfy tax withholding obligations that arose in connection with a vesting and settlement event from a restricted stock units award. Not an open market sale of securities.